China Oncology NGS Market (2025-2031) | Outlook, Competitive Landscape, Forecast, Size & Revenue, Growth, Industry, Companies, Segmentation, Value, Analysis, Trends, Share

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Oncology NGS Market Revenues & Volume, 2021 & 2031F

3.3 China Oncology NGS Market - Industry Life Cycle

3.4 China Oncology NGS Market - Porter's Five Forces

3.5 China Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 China Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 China Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F

3.8 China Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F

3.9 China Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing incidence of cancer in China

4.2.2 Growing adoption of precision medicine in oncology

4.2.3 Technological advancements in next-generation sequencing (NGS) technologies

4.3 Market Restraints

4.3.1 High cost associated with oncology NGS testing

4.3.2 Lack of reimbursement policies for NGS testing in China

4.3.3 Data privacy and security concerns regarding genomic data

6.1 China Oncology NGS Market, By Technology

6.1.1 Overview and Analysis

6.1.2 China Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 China Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F

6.1.4 China Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F

6.2 China Oncology NGS Market, By Application

6.2.1 Overview and Analysis

6.2.2 China Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F

6.2.3 China Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F

6.3 China Oncology NGS Market, By Service

6.3.1 Overview and Analysis

6.3.2 China Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F

6.3.3 China Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F

6.4 China Oncology NGS Market, By Workflow

6.4.1 Overview and Analysis

6.4.2 China Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F

6.4.3 China Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F

6.4.4 China Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F

6.5 China Oncology NGS Market, By End-use

6.5.1 Overview and Analysis

6.5.2 China Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F

6.5.3 China Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F

6.5.4 China Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F

6.5.5 China Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F

6.5.6 China Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F

7.1 China Oncology NGS Market Export to Major Countries

7.2 China Oncology NGS Market Imports from Major Countries

8.1 Average turnaround time for NGS testing

8.2 Rate of adoption of NGS in oncology clinics

8.3 Number of collaborations between NGS technology providers and healthcare institutions

9.1 China Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 China Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 China Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F

9.4 China Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F

9.5 China Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F

10.1 China Oncology NGS Market Revenue Share, By Companies, 2024

10.2 China Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters